-+ 0.00%
-+ 0.00%
-+ 0.00%

Press Release: Quantum Biopharma Announces Signing of an Agreement with a Global Pharmaceutical Contract Research Organization to Prepare an IND (Investigational New Drug) Application Package for Lucid-21-302 (Lucid-MS), A First-In-Class Treatment for Multiple Sclerosis

Dow Jones·05/20/2025 11:30:00

Please log in to view news